OrbiMed Overview
- Investor Type
- PE/Buyout
- Status
- Active
- Professionals
- 57
- Investments
- 757
- Portfolio
- 228
- Exits
- 359
OrbiMed General Information
Description
Founded in 1989, OrbiMed is a private equity firm based in New York, New York. The firm seeks to invest in the biopharmaceutical, life sciences, digital health, healthcare services, medical devices, and diagnostic sectors. The firm also manages long and short event-driven strategy hedge funds and closed-end investment trusts.
Contact Information
- 601 Lexington Avenue (at 53rd Street)
- 54th Floor
- New York, NY 10022-4629
- United States
OrbiMed Investments & Acquisitions (757)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
0000000 | 01-Mar-2022 | 00000 00000 | 0000 | Medical Records Systems | Generating Revenue | |
0000000 0000000000 | 16-Feb-2022 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 1 | 0000 000000 00.0 |
00000 00000000 000 | 16-Feb-2022 | 00000 00000 | 00000 | Discovery Tools (Healthcare) | Clinical Trials - Phase 1 | 00000 000000 00 |
00000000 000000000 | 14-Feb-2022 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - General | |
Congruence Therapeutics | 08-Feb-2022 | Seed Round | 0000 | Drug Discovery | Startup | 00000 000000 00 |
OrbiMed Exits (359)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
0000000 | 14-Jan-2022 | 0000000 000000 | 00000 |
00000 00000 | 07-Jan-2022 | 000 | 0000 |
000000 00000000000 | 31-Dec-2021 | 000 00 00000000 | |
00000 000000000000 | 31-Dec-2021 | 000 00 00000000 | |
Bioheart Biotechnology | 23-Dec-2021 | IPO | 000.00 |
OrbiMed Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore OrbiMed‘s full profile, request access.
Request a free trialOrbiMed Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialOrbiMed Team (129)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Trey Block | Chief Financial Officer | New York, NY | |||
Daniel Rhee | Chief Technology Officer | New York, NY | |||
David Wang Ph.D | Partner & Senior Managing Director | 00 | 0 | 0 | Shanghai, China |
Sunny Sharma | Partner & Senior Managing Director, Asia | 00 | 0 | 0 | Mumbai, India |
Steven Wang Ph.D | Partner & Senior Managing Director, Asia | 0 | New York, NY |